Indonesia

14 Vaccines Approved for Use in Indonesia

Protein Subunit

Serum Institute of India

COVOVAX (Novavax formulation)

Approved in 6 countries
7 trials in 3 countries
Approval Source: reuters.com
Protein Subunit

Anhui Zhifei Longcom

Zifivax

Approved in 4 countries
21 trials in 5 countries
Approval Source: reuters.com
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: reuters.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
14 trials in 6 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
25 trials in 8 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Inactivated

Shenzhen Kangtai Biological Products Co

KCONVAC

Approved in 2 countries
7 trials in 1 country
Approval Source: barrons.com
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Approval Source: reuters.com
Protein Subunit

PT Bio Farma

IndoVac

Approved in 1 country
4 trials in 1 country
Approval Source: texaschildrens.org
RNA

Walvax

AWcorna

Approved in 1 country
4 trials in 3 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com

19 in Clinical Trials in Indonesia

Protein Subunit

Anhui Zhifei Longcom

Zifivax

Approved in 4 countries
21 trials in 5 countries
Protein Subunit

West China Hospital

Recombinant (Sf9 cell)

9 trials in 5 countries
RNA

Walvax

mRNA

4 trials in 3 countries
Non Replicating Viral Vector

ReiThera

GRAd-COV2

5 trials in 12 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Protein Subunit

Adimmune Corporation

AdimrSC-2f

3 trials in 2 countries
Protein Subunit

PT Bio Farma

SARS-CoV-2 Protein Subunit Recombinant Vaccine

5 trials in 1 country
Replicating Viral Vector

Aivita Biomedical Inc

AV-COVID-19

4 trials in 2 countries
Inactivated

Airlangga University

UNAIR Inactivated COVID-19 Vaccine

3 trials in 1 country
Protein Subunit

PT Bio Farma

SARS-CoV-2 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018

RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Protein Subunit

PT Bio Farma

IndoVac

Approved in 1 country
4 trials in 1 country
Protein Subunit

Serum Institute of India

COVOVAX (Novavax formulation)

Approved in 6 countries
7 trials in 3 countries
RNA

Walvax

AWcorna

Approved in 1 country
4 trials in 3 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
RNA

Suzhou Abogen Biosciences

ABO-CoV.617.2

RNA

Suzhou Abogen Biosciences

ABO1009-DP

2 trials in 2 countries